The PHQ-9 is the most widely used questionnaire in the world for spotting depression, by doctors and psychologists alike. It measures how much depressive symptoms have bothered you over the last two weeks.
It is not a diagnosis: it is a reference point, to put words and numbers to what you are going through. Only a professional can carry out a full assessment.
🔒 Your answers stay on your device: nothing is sent or stored.
Your result
You said you have had thoughts of death or of hurting yourself. It is important to talk about it now: call 112 if you are in immediate danger, 3114 in France, or your local crisis line (Samaritans 116 123 in the UK and Ireland). You can also talk to your doctor or someone you trust. You don't have to stay alone with these thoughts.
This result is a reference point, not a diagnosis. It does not replace a professional's opinion.
What now?
If you are having suicidal thoughts or feel in danger: call 112 (emergency number in Europe), 3114 in France, or your local emergency number.
About this test
The PHQ-9 (Patient Health Questionnaire-9) was developed by Drs Robert L. Spitzer, Janet B. W. Williams, Kurt Kroenke and colleagues, with an educational grant from Pfizer Inc. No permission is required to reproduce, translate, display or distribute it.
The cut-off points 5, 10, 15 and 20 correspond to mild, moderate, moderately severe and severe symptoms. A score of 10 or more is the most widely used reference point for recommending a professional assessment. Whatever the score, any answer other than “Not at all” to question 9 is worth talking about soon.
Sources
- Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001). The PHQ-9: Validity of a brief depression severity measure. Journal of General Internal Medicine, 16(9), 606-613. https://doi.org/10.1046/j.1525-1497.2001.016009606.x
- Manea, L., Gilbody, S., & McMillan, D. (2012). Optimal cut-off score for diagnosing depression with the Patient Health Questionnaire (PHQ-9): A meta-analysis. CMAJ, 184(3), E191-E196. https://doi.org/10.1503/cmaj.110829
- Levis, B., Benedetti, A., Thombs, B. D., & DEPRESsion Screening Data (DEPRESSD) Collaboration. (2019). Accuracy of Patient Health Questionnaire-9 (PHQ-9) for screening to detect major depression: Individual participant data meta-analysis. BMJ, 365, l1476. https://doi.org/10.1136/bmj.l1476
- Diez-Quevedo, C., Rangil, T., Sanchez-Planell, L., Kroenke, K., & Spitzer, R. L. (2001). Validation and utility of the Patient Health Questionnaire in diagnosing mental disorders in 1003 general hospital Spanish inpatients. Psychosomatic Medicine, 63(4), 679-686. https://doi.org/10.1097/00006842-200107000-00021
- Carballeira, Y., Dumont, P., Borgacci, S., Rentsch, D., de Tonnac, N., Archinard, M., & Andreoli, A. (2007). Criterion validity of the French version of Patient Health Questionnaire (PHQ) in a hospital department of internal medicine. Psychology and Psychotherapy: Theory, Research and Practice, 80(1), 69-77. https://doi.org/10.1348/147608306X103641
- Pfizer Inc. PHQ and GAD-7 screeners and official translations. https://www.phqscreeners.com

